Skip to main content
Clinical Trials/NCT05747963
NCT05747963
Completed
N/A

A Prospective, Multicenter, Randomized Clinical Trial for Evaluating the Safety and Efficacy of Software-delivered Cognitive Behavioral Therapy for Insomnia in Patients With Insomnia Disorder.

Peking University Sixth Hospital5 sites in 1 country236 target enrollmentMarch 21, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Insomnia Disorder
Sponsor
Peking University Sixth Hospital
Enrollment
236
Locations
5
Primary Endpoint
The Change of Insomnia Severity from Baseline to Follow-up
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this prospective multicenter clinical trial is to evaluate the efficacy and safety of software-delivered cognitive behavioral therapy for insomnia (CBT-I) in Chinese patients with insomnia disorder (ID). The main questions it aims to answer are: (1) whether the software-delivered CBT-I is more effective than an online patient education (online-PE) at improving insomnia. (2) whether the software-delivered CBT-I is safe for treatment of insomnia symptoms.

Participants will be randomized to receive (1) a software-delivered CBT-I using automated software called 'resleep' (one kind of digital device expected to treat insomnia targeted for Chinese patients); (2) online patient education (online-PE) about sleep.

Researchers will compare the efficacy of a software-delivered CBT-I program and an online sleep education control at improving insomnia symptoms and other psychological outcomes.

Registry
clinicaltrials.gov
Start Date
March 21, 2023
End Date
March 21, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Peking University Sixth Hospital
Responsible Party
Principal Investigator
Principal Investigator

Hongqiang Sun

Professor

Peking University Sixth Hospital

Eligibility Criteria

Inclusion Criteria

  • Aged ≥18 years old, no gender limitation;
  • Own a mobile-phone, access the Internet, and be skilled in using software;
  • Meet the diagnostic criteria of insomnia disorder in the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5);
  • Insomnia symptoms appear at least 3 nights per week and last for at least 3 months;
  • ISI scores ≥ 12 ;
  • Volunteer to participate in this experiment and sign a written informed consent.

Exclusion Criteria

  • Generalized Anxiety Disorder Scale-7 (GAD-7) scores ≥ 15;
  • Patients Health Questionnaire-9 (PHQ-9) scores ≥ 20;
  • Current thoughts of suicide or self-injury (defined as PHQ-9 9th item score ≥ 1);
  • Confirmed physical diseases that may affect sleep, such as congestive heart failure, chronic obstructive pulmonary disease acute phase, cardiovascular and cerebrovascular disease acute phase, etc.
  • Current diagnosed neurological or mental illness (major depressive disorder, bipolar disorder, epilepsy, schizophrenia, etc.) that may affect sleep;
  • Diagnoses of other untreated sleep disorders, such as obstructive sleep apnea, restless leg syndrome (RLS);
  • Usual bedtime (when the subject attempts to fall asleep) is earlier than 8 p.m. or later than 2 a.m., or usual waking (arising) time is earlier than 4 a.m. or later than 10 a.m.
  • Alcohol or drug abusers (other than nicotine dependence) in the past year;
  • Pregnant or lactating women;
  • Undergoing systematic psychotherapy within the past 3 months;

Outcomes

Primary Outcomes

The Change of Insomnia Severity from Baseline to Follow-up

Time Frame: Baseline, post-intervention, follow-up (3 months after post-intervention)

The insomnia severity is assessed with the Insomnia Severity Index (ISI), a 7-item questionnaire well validated in insomnia research in multiple patient populations. The change of ISI scores from baseline to follow-up is the primary outcome.

Secondary Outcomes

  • Sleep Quality(Baseline, post-intervention, follow-up (3 months after post-intervention))
  • Insomnia Remission(Baseline, post-intervention, follow-up (3 months after post-intervention))
  • Insomnia Treatment Response(Baseline, post-intervention, follow-up (3 months after post-intervention))
  • Anxiety(Baseline, post-intervention, follow-up (3 months after post-intervention))
  • Depression(Baseline, post-intervention, follow-up (3 months after post-intervention))
  • Sleep Parameters Assessed by Sleep Diary(Baseline, post-intervention, follow-up (3 months after post-intervention))
  • Life Quality(Baseline, post-intervention, follow-up (3 months after post-intervention))

Study Sites (5)

Loading locations...

Similar Trials